Related Experiment Video
Updated: Jun 3, 2026
In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish
Published on: May 8, 2020
Bioconjugation of luminescent silicon quantum dots for selective uptake by cancer cells
Folarin Erogbogbo1, Chen-An Tien, Ching-Wen Chang
1Department of Chemical and Biological Engineering, The University at Buffalo, State University of New York Buffalo, New York 14260-4200, United States.
Abstract:
Conventional quantum dots have great potential in cancer-related imaging and diagnostic applications; however, these applications are limited by concerns about the inherent toxicity of their core materials (e.g., cadmium, lead). Virtually all imaging applications require conjugation of the imaging agent to a biologically active molecule to achieve selective uptake or binding. Here, we report a study of biocompatible silicon quantum dots covalently attached to biomolecules including lysine, folate, antimesothelin, and transferrin. The particles possess desirable physical properties, surface chemistry, and optical properties. Folate- and antimesothelin-conjugated silicon quantum dots show selective uptake into Panc-1 cells. This study contributes to the preclinical evaluation of silicon quantum dots and further demonstrates their potential as an imaging agent for cancer applications.
Insights
Biocompatible silicon quantum dots offer a safer alternative for cancer imaging and diagnostics. Conjugating these quantum dots to biomolecules like folate demonstrated selective uptake in cancer cells, paving the way for improved preclinical evaluations.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Research
Background:
- Conventional quantum dots (QDs) show promise for cancer imaging and diagnostics.
- Toxicity concerns associated with heavy metals (e.g., cadmium, lead) in traditional QDs limit their clinical application.
- Targeted delivery of imaging agents requires conjugation to biologically active molecules.
Purpose of the Study:
- To evaluate biocompatible silicon quantum dots (Si QDs) as a safer alternative for cancer imaging.
- To investigate the covalent attachment of Si QDs to various biomolecules.
- To assess the targeted uptake of functionalized Si QDs in cancer cells.
Main Methods:
- Synthesis and characterization of silicon quantum dots.
- Covalent conjugation of Si QDs to biomolecules: lysine, folate, antimesothelin, and transferrin.
- In vitro evaluation of cellular uptake in Panc-1 cancer cells.
Main Results:
- Silicon quantum dots exhibited favorable physical, chemical, and optical properties.
- Folate- and antimesothelin-conjugated Si QDs demonstrated selective uptake in Panc-1 cells.
- The study confirmed the biocompatibility and targeting potential of functionalized Si QDs.
Conclusions:
- Silicon quantum dots represent a promising, non-toxic alternative to conventional QDs for biomedical imaging.
- Biomolecule conjugation enhances the targeting specificity of Si QDs for cancer cells.
- These findings support the preclinical advancement of Si QDs for cancer diagnostic and imaging applications.
